CIBC Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $448K | Buy |
|
|||||
|
2025
Q1 | $572K | Buy |
|
|||||
|
2024
Q4 | $503K | Buy |
|
|||||
|
2024
Q3 | $473K | Buy |
|
|||||
|
2024
Q2 | $525K | Buy |
|
|||||
|
2024
Q1 | $528K | Buy |
|
|||||
|
2023
Q4 | $582K | Sell |
|
|||||
|
2023
Q3 | $573K | Buy |
|
|||||
|
2023
Q2 | $548K | Buy |
|
|||||
|
2023
Q1 | $615K | Buy |
|
|||||
|
2022
Q4 | $622K | Sell |
|
|||||
|
2022
Q3 | $699K | Buy |
|
|||||
|
2022
Q2 | $681K | Sell |
|
|||||
|
2022
Q1 | $909K | Sell |
|
|||||
|
2021
Q4 | $3.59M | Buy |
|
|||||
|
2021
Q3 | $3.07M | Buy |
|
|||||
|
2021
Q2 | $2.78M | Buy |
|
|||||
|
2021
Q1 | $2.25M | Buy |
|
|||||
|
2020
Q4 | $588K | Sell |
|
|||||
|
2020
Q3 | $1.44M | Buy |
|
|||||
|
2020
Q2 | $2.21M | Buy |
|
|||||
|
2020
Q1 | $1.45M | Sell |
|
|||||
|
2019
Q4 | $5.78M | Buy |
|
|||||
|
2019
Q3 | $1.12M | Sell |
|
|||||
|
2019
Q2 | $1.46M | Buy |
|
|||||
|
2019
Q1 | $1.46M | Sell |
|
|||||
|
2018
Q4 | $1.43M | Buy |
|
|||||
|
2018
Q3 | $1.57M | Buy |
|
|||||
|
2018
Q2 | $1.49M | Buy |
|
|||||
|
2018
Q1 | $1.21M | Buy |
|
|||||
|
2017
Q4 | $1.31M | Buy |
|
|||||
|
2017
Q3 | $1.24M | Buy |
|
|||||
|
2017
Q2 | $1.14M | Buy |
|
|||||
|
2017
Q1 | $1.04M | Buy |
|
|||||
|
2016
Q4 | $977K | Buy |
|
|||||
|
2016
Q3 | $1.08M | Buy |
|
|||||
|
2016
Q2 | $908K | Buy |
|
|||||
|
2016
Q1 | $948K | Buy |
|
|||||
|
2015
Q4 | $1.17M | Buy |
|
|||||
|
2015
Q3 | $1.05M | Buy |
|
|||||
|
2015
Q2 | $832K | Buy |
|
|||||
|
2015
Q1 | $733K | Buy |
|
|||||
|
2014
Q4 | $508K | Buy |
|
|||||
|
2014
Q3 | $393K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $375K | Buy |
|